Search Press releases Keywords From To 24 Mar 2023 Acquisition of own shares Read More 18 Mar 2023 Bimekizumab Phase 3 Data in Hidradenitis Suppurativa Show Clinically Meaningful, Deep and Maintained Response over 48 Weeks Read More 17 Mar 2023 Acquisition of own shares Read More 16 Mar 2023 UCB to Present Eight Bimekizumab Abstracts at AAD 2023 with Results from Studies in Psoriasis, Psoriatic Arthritis and Hidradenitis Suppurativa Read More 15 Mar 2023 Aitia and UCB Announce Strategic Drug Discovery Collaboration in Huntington's Disease Read More 10 Mar 2023 Acquisition of own shares Read More Pagination First page Previous page Previous … Page 34 Page 35 Page 36 Page 37 Current page 38 Page 39 Page 40 Page 41 Page 42 … Page 38 of 67 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
